Methotrexate 5 mg/2 ml Injection
Authorisation PA0822/206/001 · Pfizer Healthcare Ireland Unlimited Company
- Licence holder
- Pfizer Healthcare Ireland Unlimited Company (all products →)
- Active substance
- Methotrexate
- Clinical trials
- 120 clinical trials →
- Dosage form
- Solution for injection
- Route of administration
- Intravenous use
- ATC codes
- L01BA, L01BA01
- First authorised
- 12/12/1984
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Methotrexate: supply and approvals
48 authorised products on the HPRA list contain Methotrexate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- Methotrexate: Shortage resolved, first published 9 Aug 2023
- US shortage (FDA)
- Methotrexate Sodium Injection: in shortage, updated 16 Nov 2026
- Germany (BfArM)
- 14 supply notices, e.g. Methofill 20 mg Injektionslösung im Fertiginjektor (30 Jun 2026 to 31 Dec 2027)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 41 years (since 12 December 1984). The HPRA list marks it as marketed in Ireland.
Other medicines with Methotrexate in Ireland
47 other products on the HPRA list contain Methotrexate, from 10 licence holders; 21 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Methofill 10 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methofill 12.5 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methofill 15 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methofill 17.5 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methofill 20 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methofill 22.5 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methofill 25 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methofill 30 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methofill 7.5 mg solution for injection in pre-filled injector | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Methotrexate 1 g/10 ml Injection | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Methotrexate 2.5 mg Tablets | Abcur AB | National authorisation (PA) | Marketed |
| Methotrexate 2.5 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
Other substances in ATC group L01BA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 5 other active substances share the group L01BA with this product:
Pemetrexed (8) · Pemetrexed disodium (3) · Pemetrexed ditromethamine (3) · Pemetrexed diacid (1) · Pemetrexed Disodium 2.5 hydrate (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Pfizer Healthcare Ireland Unlimited Company holds 109 products on the HPRA list, with 63 different active substances; 104 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.